The 25th Annual 2014 HIMSS Leadership Survey examines topics crucial to healthcare leaders including IT priorities, issues driving and challenging technology adoption and IT security. One finding from this year’s survey concerns the perceived impact financial resources are having on IT implementations. A majority of the survey participants (65 percent) reported IT budget increases, which is likely a contributing factor to the transition to a paperless environment. However, a lack of adequate financial resources tops the list of barriers to successful IT implementation. This is a shift from the past two years when the primary IT challenge was insufficient and untrained staffing resources.


TeraRecon, a provider of medical image management solutions, debuted it’s iNteract+ solution at the 2014 Healthcare Information and Management Systems Society (HIMSS) annual conference.  

ScImage announced availability of a Master Patient Index (MPI) Translator that provides healthcare professionals diagnostic imaging data residing in disparate systems, often located at unrelated facilities.

Medical X-ray exams are part of a comprehensive physical of football players at Indiana University Health Methodist Hospital in Indianapolis during the NFL Combine. The hospital uses a Carestream DRX-1 detector to produce digital X-ray exams of more than 300 athletes over several days.

The fifth edition of Breast Imaging-Reporting and Data System (BI-RADS) Atlas issued by the American College of Radiology (ACR) included changes in breast density reporting categories. Volpara Solutions, producers of VolparaDensity software, said this is a step toward the provision of accurate breast density measurements to women by the renewed emphasis on volumetric assessments. 

Blackford Analysis, a software provider with products to accelerate medical image comparison, introduced its software development kit (SDK) at the HIMSS Annual Conference and Exhibition in Orlando, Fla.


Until recently, cancer patients looking for a precise form of proton radiation therapy – "pencil-beam scanning" – had to narrow their search to about a half dozen centers in the United States that offer this treatment on a limited basis.


Guerbet, a contrast agent specialist for medical imaging, received U.S. Food and Drug Administration (FDA) approval for a manufacturing plant for Lipiodol (ethiodized oil) Injection, in Montreal, Canada.

Subscribe Now